MedPath
NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

国药准字SJ20171033

August 10, 2022

S20171033

Drug Information

重组人粒细胞刺激因子注射液

惠尔血

注射剂

75μg/0.3ml/支

生物制品

August 10, 2022

August 9, 2027

Company Information

Applicant Company

1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

nipro pharma corporation ise plant

647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath